SLC2A1 and hepatocellular carcinoma: Subsequently, we identified that SLC2A1-DT promoted glycolysis, proliferative, and invasive ability in HCC cells by stabilizing β-catenin protein, which transcriptionally induced the expression of glycolytic genes.